Dr. John Moroney, MD
Claim this profileUniversity of Chicago
Expert in Ovarian Cancer
Studies Ovarian Tumors
16 reported clinical trials
37 drugs studied
Area of expertise
1Ovarian Cancer
Global LeaderStage IV
Stage III
AKT positive
2Ovarian Tumors
Stage IV
Stage III
AKT positive
Affiliated Hospitals
Clinical Trials John Moroney, MD is currently running
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting1 award Phase 1 & 210 criteria
Mirvetuximab + Bevacizumab
for Ovarian Cancer
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting2 awards Phase 3
More about John Moroney, MD
Clinical Trial Related4 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments John Moroney, MD has experience with
- Paclitaxel
- Bevacizumab
- Letrozole
- Abemaciclib
- Atezolizumab
- Mirvetuximab Soravtansine
Breakdown of trials John Moroney, MD has run
Ovarian Cancer
Ovarian Tumors
Endometrioid Carcinoma
Endometrial Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John Moroney, MD specialize in?
John Moroney, MD focuses on Ovarian Cancer and Ovarian Tumors. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are Stage III.
Is John Moroney, MD currently recruiting for clinical trials?
Yes, John Moroney, MD is currently recruiting for 4 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that John Moroney, MD has studied deeply?
Yes, John Moroney, MD has studied treatments such as Paclitaxel, Bevacizumab, Letrozole.
What is the best way to schedule an appointment with John Moroney, MD?
Apply for one of the trials that John Moroney, MD is conducting.
What is the office address of John Moroney, MD?
The office of John Moroney, MD is located at: University of Chicago, Chicago, Illinois 60637 United States. This is the address for their practice at the University of Chicago.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.